Sign In
Buy AIM
$0.732
-0.0947 (-11.46%)
At Close: Jun 03, 2026
Aimia Inc. (AIM:CA) Shareholder/Analyst Call Transcript
02:40pm, Wednesday, 13'th May 2026
Aimia Inc. (AIM:CA) Shareholder/Analyst Call Transcript
Candor Technology Integrates with Freddie Mac's AIM Check API to Automate Income Calculations
12:01pm, Wednesday, 13'th May 2026
ALPHARETTA, Ga., May 13, 2026 (GLOBE NEWSWIRE) -- Candor Technology, Inc., a leader in AI-driven mortgage decisioning, is now integrated with Freddie Mac's AIM Check API, enabling automated income ca
Aimia Inc. (AIM:CA) Q1 2026 Earnings Call Transcript
11:20am, Wednesday, 13'th May 2026
Aimia Inc. (AIM:CA) Q1 2026 Earnings Call Transcript
Jersey Oil and Gas well placed to unlock value - broker
11:14am, Tuesday, 12'th May 2026
Cavendish sees more than fivefold upside in Jersey Oil and Gas PLC (AIM:JOG, OTC:JYOGF), arguing that the AIM-listed North Sea developer remains well placed to unlock value from its Greater Buchan Are
Bullish broker tips 88 Energy for substantial upside
09:07am, Monday, 11'th May 2026
Cavendish sees huge upside (more than thirteenfold) for 88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ), with the bullish house-broker highlighting that the explorer has reshaped its Namibia
88 Energy amends Namibia venture agreement as it focusses on Alaska
03:02am, Monday, 11'th May 2026
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) announced it has secured its 20% working interest in Namibia's PEL 93 on an unconditional basis while cutting about US$15 million of minimum fut
AIM ImmunoTech, Inc. Announces Exercise of Warrants for Approx. $4.2 Million in Gross Proceeds
08:40am, Friday, 08'th May 2026
OCALA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech, Inc. (NYSEAM:AIM) (“AIM ImmunoTech” or the “Company”), a late-stage biotechnology company focused on the discovery and development
Final UPMC Primary Endpoint Report Details Positive Data from Ovarian Cancer Clinical Trial Combining Ampligen, Pembrolizumab and Cisplatin Final UPMC Primary Endpoint Report Details Positive Data fro
Active Energy Group advances digital infrastructure push in the UAE
03:34am, Thursday, 07'th May 2026
Active Energy Group PLC (AIM:AEG, OTCID:AEUSF) told investors that its digital infrastructure push in the UAE has moved a step forward after its subsidiary signed an agreement aimed at supporting li
Union Jack Oil says Crossroads well has spud
03:08am, Wednesday, 06'th May 2026
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF, FRA:1UJ0) said drilling has started at the Crossroads Well in Oklahoma, putting the AIM-quoted explorer on a short timeline to the next operational readout fr
Union Jack Oil updates on timeline for Crossroads Well
03:04am, Friday, 01'st May 2026
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF, FRA:1UJ0) said the rig for the Crossroads Well in Southern Oklahoma remains under maintenance and repair, pushing the next drilling timetable marker into earl
Europa Oil & Gas rallies as firm plans appeal in Yorkshire planning dispute
04:02am, Monday, 27'th Apr 2026
Europa Oil & Gas (Holdings) Plc (AIM:EOG, FRA:EGN) opened Monday's session on the back foot, before rallying, in the wake of the latest UK planning dispute for onshore oil and gas. The AIM-listed oil
Serval Resources makes AIM debut after copper acquisitions in Namibia and Botswana
03:07am, Monday, 27'th Apr 2026
Oscillate PLC (LSE:SRVL), the AIM-bound shell company rebranding as Serval Resources, has completed the acquisition of Kalahari Copper and begun trading on London's junior market, raising nearly £3 m
Mirriad Advertising warns of imminent collapse as funding search fails
04:46am, Thursday, 23'rd Apr 2026
The AIM-listed virtual product placement company says it may have to enter administration or liquidation in the near term after failing to secure fresh capital Mirriad Advertising PLC (AIM:MIRI, FRA:8
CelLBxHealth shares rise 8% on Royal Marsden lung cancer collaboration
06:01am, Monday, 20'th Apr 2026
CelLBxHealth PLC (AIM:CLBX, FRA:DWV) shares rose 8% to 0.99p after the AIM-listed circulating tumour cell specialist announced a research collaboration with The Royal Marsden NHS Foundation Trust to
